SNDL Inc. has announced significant updates following its 2026 Annual and Special Meeting of Shareholders, including preliminary third-quarter financial results and plans for capital return initiatives. The company reported record quarterly free cash flow of approximately C$20 million, which is expected to enhance shareholder value.
During the meeting, shareholders elected all five director nominees and approved the appointment of the company’s auditor. However, a proposed consolidation of common shares did not receive the required two-thirds approval, with only 54.1% of votes in favor. Consequently, SNDL will not proceed with the share consolidation.
According to the filing dated October 15, 2026, SNDL's preliminary third-quarter results indicate that the free cash flow of approximately C$20 million represents the highest quarterly figure in the company's history. This achievement was aided by the unwinding of the company's captive insurance arrangement and effective working capital management.
“For the third quarter, we expect to report the highest quarterly free cash flow in SNDL’s history,” said Zach George, CEO of SNDL. “We remain focused on capturing the many opportunities available to further optimize our operating footprint, enhance performance and create a scalable platform for profitable growth.”
SNDL's recent performance has prompted the company to accelerate its return of capital to shareholders. The company repurchased approximately 5.4 million common shares during the third quarter, totaling about 21.8 million shares repurchased over the past year for approximately C$43.4 million. This reflects a strong commitment to returning value to shareholders while reducing the overall share count.
Additionally, SNDL's Board of Directors is considering a substantial issuer bid (SIB) for an aggregate purchase price not exceeding C$50 million, with a price per share not greater than C$1.92 (US$1.35). This bid would represent a 17.4% premium to the closing price of the company’s shares on Nasdaq as of October 14, 2026. The launch of the SIB is contingent on regulatory approvals and will occur after the company reports its third-quarter earnings.
As part of its ongoing capital allocation strategy, SNDL intends to renew its existing share repurchase program, which is set to expire on November 20, 2026. This renewal will allow SNDL to continue repurchasing shares when deemed beneficial for the company and its shareholders.
The filing also highlights SNDL's strategic focus on its U.S. medical cannabis operations. The company has increased its indirect interest in Surterra Holdings, a vertically integrated cannabis operator, from approximately 67% to 92%. This move is expected to enhance SNDL's economic exposure to the U.S. market and provide necessary liquidity for Surterra to achieve its objectives.
SNDL is also taking steps to improve the profitability of its Canadian cannabis operations by exiting unprofitable segments and focusing on higher-value products. The company has reached an agreement with the Alcohol and Gaming Commission of Ontario to resolve regulatory matters, which is expected to pave the way for normalized operations and renewed growth.
Overall, SNDL's recent developments indicate a strong commitment to enhancing shareholder value through strategic capital allocation and operational improvements. As the medicinal chemicals and botanical products industry continues to evolve, SNDL's proactive measures may set a precedent for its competitors.
Details regarding the voting results and further financial disclosures will be filed on SEDAR+ and furnished with the company’s applicable filings in the United States.